baber/WOPTO huggingface dataset:
Patent AU-2019380483-B2 (AU)
Title: Generation of an inhalable medium
Inventor: BISHOP DAVID
IPC: A24B15/16
Filed: 2019-11-04
Granted: 2022-08-18
Abstract: Disclosed herein is a composition (14) for use in generating an inhalable medium, the composition comprising an extruded material wherein the extruded material comprises a flavourant and no tobacco-derived components.
Patent AU-2019393898-B2 (AU)
Title: Compositions and methods for reducing pesticide-induced plant damage and improving plant yield
Inventor: WOZNIAK ELIZABETH
IPC: C12N1/20
Filed: 2019-12-06
Granted: 2023-03-02
Abstract: Agricultural management products and method, particularly plant, seed, and soil treatment products and methods of manufacturing and using the same. Compositions and methods for reducing chemical pesticide-induced plant damage and/or improving plant yield, including combinatorial compositions and methods for treating plants, seed, and soil. Plant treatment products include a plant treatment component and, preferably mixed with, a microbial fermentation product. The microbial fermentation product includes cellular material of cultured microorganisms and one or more anaerobic metabolite products of the cultured microorganisms. Preferably, the microbial fermentation product comprises a whole culture lysate of a microbial fermentation suspension culture, including liquid fermentation culture medium components and lysed microorganisms. The plant treatment component of the product includes one or more pesticides or plant growth regulators. Plant treatment products can be applied to or around plants or seeds to enhance growth, health, or productivity of the plants.
Patent AU-2019410075-B2 (AU)
Title: Antibodies binding to CD3
Inventor: FREIMOSER-GRUNDSCHOBER ANNE
IPC: C07K16/30
Filed: 2019-12-19
Granted: 2022-08-25
Abstract: The present invention generally relates to antibodies that bind to CD3, including multispecific antibodies e.g. for activating T cells. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies, and to methods of using them in the treatment of disease.
Patent AU-2020201675-B2 (AU)
Title: Tailings deposition
Inventor: FILMER ANTHONY OWEN
IPC: B01D17/00
Filed: 2020-03-06
Granted: 2021-11-04
Abstract: THIS invention relates to a method of disposing of residues from the 
comminution and processing of ores. The method includes the steps of 
classifying the processing residues into a water permeable sand fraction and 
a tailings fraction and depositing the tailings fraction and the sand fraction to 
form a multilayer structure contained by at least one containment wall (14) 
with the sand fraction forming continuous channels (12) through the tailings 
fraction (10) to allow water contained in the tailings and sand to flow by 
gravity, through the sand channels, to water discharge points (16), and 
recovering the water (18) from the water discharge points.
1/3 
10 I101 
12 
12 
12 
12 
10 18 
10A Fig. 1 
22 
G 
20,/20 10 20 20 
12\2 
Fig. 2A 
12 12 
10 
12 Fig. 2B
Patent AU-2020223695-B2 (AU)
Title: Dust removal filter cartridge
Inventor: ZENG ZHISONG
IPC: B01D46/52
Filed: 2020-08-26
Granted: 2022-02-17
Abstract: The invention relates to the technical field of filtering equipment, and discloses a dust removal 
filter cartridge. The dust removal filter cartridge includes a filter material and a filter net 
arranged in the filter material. A top cover is arranged on a top end of the filter material, and an 
air outlet is provided in the top cover. A bottom end of the filter material is sealed with a bottom 
cover. An inner side of the filter material is provided with binding tapes which are adhesively 
fixed on the filter material. An outer surface of the filter material is an effective filtering surface 
for dust removal, and the binding tapes are arranged on the inner side of the filter material.  
During the dust removal process, filtering area of an outer surface of a filter paper increases, and 
the filtering effect is good.
3/3 
52 53 
1 5 
51 2 
Figure 5
Patent AU-2020293073-B2 (AU)
Title: Implantable medical device without a wire-wound coil configured to receive wireless power from an external charger
Inventor: CHEN JOEY
IPC: A61N1/372
Filed: 2020-06-08
Granted: 2023-07-27
Abstract: Implantable medical devices (IMDs) are disclosed which are capable of wirelessly receiving power from a magnetic field to power the IMD or charge its battery, but which do not use a wire-wound coil for magnetic field reception. The IMD can include a case housing control circuitry for the IMD, in which at least a portion of the case is conductive, with a case current formed in the conductive case portion in response to the magnetic field. The IMD includes power reception circuitry inside the case, and includes various examples of first and second electrical connections used to divert at least some of the case current as a power current to the power reception circuitry, thus allowing the power reception circuitry to use the power current to provide power to the IMD or to charge its battery.
Patent AU-2020399502-B2 (AU)
Title: Absorbent component
Inventor: KANDEGEDARA DEEYAYAWATHTHE GEDARA RUMESH MAHELA
IPC: A61F13/14
Filed: 2020-09-07
Granted: 2023-08-17
Abstract: The present invention generally relates to an absorbent component (100) for use in a garment. The absorbent component (100) comprises: a first layer composite (120) comprising a first foam layer (122) and a first liquid impermeable layer (124); an absorbent layer composite (140) bonded to the first liquid impermeable layer (124) for absorbing bodily fluids; and a second liquid impermeable layer (164) bonded to the absorbent layer composite (140) and first layer composite (120) to contain the bodily fluids absorbed by the absorbent layer composite (140), wherein the second liquid impermeable layer (164) forms an opening (166) for receiving the bodily fluids to the absorbent layer composite (140); and wherein the first foam layer (122) is moulded to shape the absorbent component (100).
Patent AU-2021202903-B2 (AU)
Title: Gesture based graphical user interface for managing concurrently open software applications
Inventor: CHAUDHRI IMRAN
IPC: G06F3/048
Filed: 2021-05-07
Granted: 2022-09-01
Abstract: UU34b4tbi 
ABSTRACT 
A method includes displaying a first application view. A first input is detected, and an 
application view selection mode is entered for selecting one of concurrently open applications 
for display in a corresponding application view. An initial group of open application icons in 
a first predefined area and at least a portion of the first application view adjacent to the first 
predefined area are concurrently displayed. The initial group of open application icons 
corresponds to at least some of the concurrently open applications. A gesture is detected on a 
respective open application icon in the first predefined area, and a respective application view 
for a corresponding application is displayed without concurrently displaying an application 
view for any other application in the concurrently open applications. The open application 
icons in the first predefined area cease to be displayed, and the application view selection 
mode is exited.
Patent AU-2022200379-B2 (AU)
Title: System and method of administering a pharmaceutical gas to a patient
Inventor: MONTGOMERY FREDERICK J
IPC: A61M16/00
Filed: 2022-01-20
Granted: 2024-01-04
Abstract: A method and system for delivering a pharmaceutical gas to a patient. The method and 
system provide a known desired quantity of the pharmaceutical gas to the patient independent of 
the respiratory pattern of the patient. The preferred pharmaceutical gases are CO and NO, both of 
5 which are provided as a concentration in a carrier gas. The gas control system determines the 
delivery of the pharmaceutical gas to the patient to result in the known desired quantity (e.g. in 
molecules, milligrams or other quantified units) of the pharmaceutical gas being delivered. Upon 
completion of that known desired quantity of pharmaceutical gas over a plurality of breaths, the 
system can either terminate any further delivery of the pharmaceutical gas or can activate an 
10 alarm to alert the user that the known quantity has been delivered. The system also has alarm 
functions to alert the user of possible malfunctions of the system.
Patent JP-3423909-B2 (JP)
IPC: G02F1/1337
Filed: 2000-01-13
Granted: 2003-07-07
Abstract: PROBLEM TO BE SOLVED: To provide an active matrix liquid crystal display unit adopting horizontal electric field system, that has a wide angle of visibility with a uniform tone, and realizes an angle of visibility comparable to a cathode-ray tube, and that enables improvement in image quality. SOLUTION: This unit is an active matrix liquid crystal display unit equipped with a pair of substrates, a liquid crystal layer held between the pair of substrates, plural video signal lines DL formed on one substrate, plural scanning signal lines GL which is formed on one substrate and which cross the video signal lines DL, pixel electrodes SL and the counter electrodes CL which are formed on one substrate, and plural pixels which are formed in matrix in the crossing area of the plural video signal lines and scanning signal lines.  The liquid crystal layer is provided with initial orientation of liquid crystal elements which is nearly vertical to the scanning signal lines GL, and the pixel electrodes SL and the counter electrodes CL are parallel to the initial orientation of the liquid crystal elements in the display area of each pixel, crossing each other at two or more angles outside the display area of each pixel.
Patent JP-4652566-B2 (JP)
IPC: C12N15/09
Filed: 1999-01-12
Granted: 2011-03-16
Abstract: The present invention provides diagnostic tests in which to identify individuals predisposed to essential hypertension, and the genetic, cellular and biochemical tools in which to carry out these tests. The present invention also provides methods of screening substances for antihypertensive properties in which to facilitate drug discovery for antihypertensive agents. A wide variety of tools are provided for these purposes as well. The present invention further provides compositions and methods for normalizing sodium transport in kidney cells of individuals having essential hypertension.
Patent JP-4357113-B2 (JP)
IPC: G01N33/544
Filed: 1999-01-21
Granted: 2009-11-04
Abstract: A process for detecting an analyte which process comprises (a) contacting a sample suspected of containing said analyte with a containment means comprising a barrier which separates signal generating reagents from said sample, in the presence of an element which interacts specifically with said analyte, under conditions whereby interaction between the analyte and the said element results in activation of the signal generating reagents within the containment means on the side of the barrier opposite to the sample, and (b) detecting any signal generated and retained within the containment means from the sample side of the barrier. The process of the invention provides for sensitive detection of very small numbers of analyte materials using measurement techniques which include counting methods such as flow cytometry.
Patent JP-3581651-B2 (JP)
IPC: G11B7/24003
Filed: 1999-03-11
Granted: 2004-10-27
Abstract: Transparent and semitransparent diffractive elements, particularly holograms with a diffractive pattern created at least in one of two following layers with different index of refraction: a transparent bearing layer (1) from polymer or copolymer having index of refraction n<1.7, and a holographic effect-enhancing, high refraction index layer (2) formed by chalcogenide based substances comprising at least one element from the group sulphur selenium, tellurium, said layer (2) has n>1.7 and its melting temperature is lower than 900° C. The diffractive element can further contain a protective layer (6) and/or an adhesive layer (7) and/or a fragile layer (8) and/or an anchoring layer (9). The diffractive pattern is either formed in said bearing layer (1) and subsequently a high refraction index layer (2) (comprising one or more layers chalcogenide based substances of different composition, which can be deposited subsequently or simultaneously) is deposited on the said layer (1), or said layer (2) is firstly deposited onto said layer (1) and diffractive pattern is mechanically formed into this system.
Patent JP-4786032-B2 (JP)
IPC: C07D413/10
Filed: 1999-05-04
Granted: 2011-10-05
Abstract: 3-(2-Alkylthio-5-acylphenyl)-isoxazoles (I) are prepared by a multi-stage process via 3-(2-aminophenyl)-isoxazole intermediates (VI). Also new are various oxime and isoxazole derivative intermediates, including (VI); and methods for preparing oximes (XV) and thioethers (XIX) . Preparation of 3-(2-alkylthio-5-acylphenyl)-isoxazoles of formula (I) involves preparing a 3-(2-aminophenyl)-isoxazole intermediate of formula (VI), then halogenating, thioalkylating, oxidizing and acylating to give (I). [Image] R 1, R 3-R 5 : H or 1-6C alkyl; or R 4+R 5 : a bond; R 2 : 1-6C alkyl; R 6 : heterocycle; n : 0-2. Independent claims are included for: (i) new oxime and isoxazole derivative intermediates of formulae (III), (X) (including (VI)) and (XII); (ii) the preparation of benzaldoxime derivatives of formula (XV), involving the reaction of toluene derivatives of formula (XVI) with an organic nitrite of formula R-ONO in presence of a base, where the process optionally further includes the conversion of the oxime group of (XV) into aldehyde, nitrile or nitrile oxide; (iii) the preparation of thioethers of formula (XIX), involving the reaction of an aniline of formula (XX) with a dialkylsulfide of formula R 2SSR 2 (VII) in presence of a catalyst; and (iv) new benzaldoxime compounds of formula (XV'). [Image] [Image] A : NO 2, NH 2 or SR 2; X : NO 2 or SO 2R y; R x, R y : inert substituents; m : 0-4; p : 0-5; R' 1 : H, 1-6C alkyl, halo, 1-6C alkoxy or 1-6C alkylthio; X' : S(O) nR' y; R' y : H, Cl or Br '' in the para position of the phenyl ring to X' '' (sic). ACTIVITY : Herbicidal. MECHANISM OF ACTION : None given.
Patent JP-4643006-B2 (JP)
IPC: B01J39/18
Filed: 1999-06-16
Granted: 2011-03-02
Abstract: A process for separation of a compound from a solution by cation exchange. One characterizing feature is that cation exchanger used carries a number of ligands X-Y(Z)n and requires an elevated ionic strength for elution a bound compound compared to standard cation exchangers. In the ligand a) X is -O-, -S(R1)- or -N(R1)(R2)-; b) Y may be: 1) a 5 or 6 membered cyclic structure containing dou ble bonds, preferably an aromatic group, or 2) an alicyclic C5-C6 group or an aliphatic, straight or branched, C1-C3 group with the possibility that the chain joining X with Z may be interrupted by 1 or 2 ether oxygen or thioether sulphur atoms and with the proviso that X is not -O- or -S-; c) Z is cation exchanging group with a negative total charge or a protonated form thereof; and d) n is an integer > 0. The method is further characterized in that the binding is taking place at a pH at which the ligand has a net charge.
Patent JP-4746748-B2 (JP)
IPC: A61F9/007
Filed: 1999-10-07
Granted: 2011-08-10
Abstract: An instrument for measuring aberration refraction of an eye is provided, having: a lens system defining an instrument optical axis and an alignment device for aligning the visual axis of the eye with the instrument optical axis. A light source produces a probing beam that is projected through the lens system parallel to the instrument optical axis and is selectably positionable partially off-set from the instrument optical axis for entering the eye parallel to the instrument optical axis at a plurality of locations on the cornea of the eye. A first photodetector measures the position of a first portion of the probing beam light scattered back from the retina of the eye to measure aberration refraction of the eye at a plurality of locations. A second photodetector synchronously measures the position of a second portion of the probing beam light reflected back from the cornea of the eye.
Patent JP-4502511-B2 (JP)
IPC: H02K3/50
Filed: 1999-11-29
Granted: 2010-07-14
Abstract: In order to reduce the electrical losses caused by current displacement in conductors in a conductor configuration having a number of electrical conductors for carrying power to, and away from, a winding configuration, which has a number of windings, in an electrical machine, in particular a generator, the respective conductors for carrying power to and away from a respective winding are adjacent to one another. The magnitude of the difference between the phase angles of current vectors of a conductor pair is thus as large as possible, and, in particular it is 180°.
Patent JP-4358447-B2 (JP)
IPC: A61B18/24
Filed: 2000-01-14
Granted: 2009-11-04
Abstract: Methods for delivering light to a treatment site of a patient to administer a light therapy thereto are provided. A method includes steps of providing a portable power source, and a light source configured to provide light suitable for the light therapy for a period of at least two hours, and an optical fiber; positioning a distal portion of the optical fiber that is adapted to be disposed at the treatment site within a patient's body, where the light generated by the light source and conveyed by the optical fiber exits from the distal portion of the optical fiber; energizing the light source with the portable power supply; and administering the light treatment to the treatment site with the light source, wherein the patient is ambulatory without interruption of the light therapy during the treatment.
Patent JP-3611787-B2 (JP)
IPC: G03B21/14
Filed: 2000-05-12
Granted: 2005-01-19
Abstract: A system for separating light into different spectrums and for recombining the light includes at least one polarizing beamsplitter and at least one retarder stack configured to condition the polarization of input light differently for different spectrums. A device embodying the invention could utilize multiple polarizing beamsplitters and multiple retarder stacks. Alternatively, a system could utilize a single polarizing beamsplitter and a single retarder stack in combination with one or more dichroic beamsplitters. In preferred embodiments, one or more reflective modulator panels are included to separately modulate each separated spectrum of light. Such an embodiment can be used for a color projection system. In each of the embodiments that utilize modulators, distances between the modulators and the focusing optics is essentially the same.
Patent JP-5563180-B2 (JP)
IPC: C12N9/56
Filed: 2000-05-10
Granted: 2014-07-30
Abstract: Subtilase enzymes of the I-S1 and I-S2 sub-groups having an additional amino acid residue in position 97 of the active site loop (b) region from positions 95 to 103. Variant subtilases exhibit improved wash performance in a detergent in comparison to its parent enzyme.
Patent JP-5008797-B2 (JP)
IPC: H04M1/725
Filed: 2001-01-25
Granted: 2012-08-22
Abstract: PROBLEM TO BE SOLVED: To stop the function as a telephone at use of an application and make it function as an exclusive terminal for each application such as a gate function, a music play back function, etc. SOLUTION: This portable telephone, which has the additional function of applications such as a play back function, a gate function, etc., has an input part 16 which has a waiting action stop mode for stopping a waiting function and serves as an input means for setting each kind of action mode including the above waiting action stop mode, and a CPU 10 which serves as a control means for stopping a telephone function and making only the above application feasible when the above waiting action stop mode is set by the above input means.
Patent JP-5079945-B2 (JP)
IPC: C08J3/12
Filed: 2001-02-22
Granted: 2012-11-21
Abstract: Fine-particle, filled rubber powders prepared by precipitation from aqueous mixtures of a filler suspension and a rubber-latex emulsion in the absence of water-soluble salts of metals of groups IIa, IIb, IIIa, or VIII of the Periodic Table of the Elements and in the absence of alkali metal silicate are used for vulcanizable rubber mixtures.
Patent JP-3823806-B2 (JP)
IPC: F17C13/08
Filed: 2001-10-30
Granted: 2006-09-20
Abstract: A support structure for a container ( 1 ) provided with neck portions ( 47, 49 ) on both ends of a longitudinal direction thereof which includes; a first support member ( 5 ) for supporting one of the neck portions ( 47, 49 ) of the container ( 1 ); a second support member ( 7 ) for supporting the other of the neck portions ( 47, 49 ) of the container ( 1 ), and elastically pressing the container ( 1 ) in the longitudinal direction thereof; and a frame ( 3 ) to which the first and second support members ( 5, 7 ) are fixed.
Patent JP-4596715-B2 (JP)
IPC: G06F12/00
Filed: 1999-06-10
Granted: 2010-12-15
Abstract: Computer-readable medium storing a data structure for supporting persistant storage of a set of data, the data structure including: (a) at least an oldest version of the set of data in a first memory area the first memory area including at least one first tag for uniquely identifying the oldest version, and (b) at least a most recently updated version of the set of data in a second, distinct memory area, the second memory area including at least one second tag for uniquely identifying the most recently updated version. The invention also relates to a computer arrangement including a processor and such a computer-readable medium, as well as to a method of updating sets of data having such tagged-data structures.
Patent JP-4160752-B2 (JP)
IPC: H01L21/329
Filed: 2000-09-11
Granted: 2008-10-08
Abstract: The semiconductor device includes a first semiconductor region made from n-conducting SiC and a second semiconductor region made from p-conducting SiC. A Schottky contact layer electrically contacts the first semiconductor region, and an ohmic p-contact layer electrically contacts the second semiconductor region. Both contact layers consist of a nickel-aluminum material. This allows both contact layers to be annealed together without adversely effecting the Schottky contact behavior.
Patent JP-5019688-B2 (JP)
IPC: C07H21/04
Filed: 2000-12-08
Granted: 2012-09-05
Abstract: Oligonucleotide-fluorophore-quencher conjugates wherein the fluorophore moiety has emission wavelengths in the range of about (300) to about (800) nm, and or where the quencher includes a substituted 4-(phenyldiazenyl)phenylamine structure provide improved signal to noise ratios and other advantageous characteristics in hybridization and related assays. The oligonucleotide-fluorophore-quencher conjugates can be synthesized by utilizing novel phosphoramidite reagents that incorporate the quencher moiety based on the substituted 4-(phenyldiazenyl)phenylamine structure, and or novel phosphoramidite reagents that incorporate a fluorophore moiety based on the substituted coumarin, substituted 7-hydroxy-3H-phenoxazin-3-one, or substituted 5,10-dihydro-10 [phenyl]pyrido[2,3-d;6,5-d']dipyrimidine-2,4,6,8-(1H, 3H, 7H, 9H, 10H)-tetrone structure. Oligonucleotide-fluorophore-quencher-minor groove binder conjugates including a pyrrolo[4,5-e]indolin-7-yl}carbonyl)pyrrolo[4,5-e]indolin-7-yl]carbonyl}pyrrolo[4,5-e]indolin-7-caroxylate (DPI3) moiety as the minor groove binder and the substituted 4-(phenyldiazenyl)phenylamine moiety as the quencher, were synthesized and have substantially improved hybridization and signal to noise ratio properties.